welbournes

Class 4 Medicines Defect Information: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug alert number: EL (24)A/39 Date issued: 19 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Company name: Glenmark Pharmaceuticals Europe [...]

The post MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/08/2024) announced the following list of price concessions for August 2024: Drug Pack size Price concession Amiloride 5mg tablets 28 £15.70 Amisulpride 200mg tablets 60 £28.42 Bimatoprost 300micrograms/ml / [...]

The post August 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) Drug alert number: EL (24)A/37 Date issued: 14 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) Company [...]

The post MHRA Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices for all strengths of Latuda® (lurasidone) tablets dispensed in April 2024. On 1 April 2024, there was an increase in the NHS list prices of Latuda® (all strengths) manufactured [...]

The post Latuda®(lurasidone) tablets – retrospective reimbursement price adjustment for April 2024 appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England on behalf of community pharmacy contractors, the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for EpiPen® and Jext® (adrenaline) preparations dispensed in July 2024. On 1 July 2024, there was an increase in the NHS list prices of EpiPen® and Jext® preparations manufactured by [...]

The post EpiPen® and Jext® – reimbursement price changes for July 2024 appeared first on Community Pharmacy England.